Innovate Biopharmaceuticals Announces Participation at the Jefferies 2018 London Healthcare Conference
31 oct. 2018 09h00 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals Announces Positive Effect of Larazotide Acetate on reducing Intestinal Permeability in a NASH Preclinical Study
29 oct. 2018 07h00 HE
|
Innovate Biopharmaceuticals, Inc
Top line results showed larazotide having a significant effect on intestinal permeability, a mechanism thought to be key for bacterial translocation leading to NAFLD/NASH Further preclinical data in...
Innovate Biopharmaceuticals Announces Participation at the Ladenburg Thalmann 2018 Healthcare Conference
01 oct. 2018 08h30 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City.
06 sept. 2018 07h30 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...
Innovate Biopharmaceuticals Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City September 4-6, 2018
31 août 2018 22h00 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals Enters into an Agreement with Amarex Clinical Research for Data Management and Biostatistics for Phase 3 Celiac Disease Trial
23 août 2018 07h00 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...
Innovate Biopharmaceuticals Reports Second Quarter 2018 Earnings and Key Corporate Highlights
15 août 2018 07h10 HE
|
Innovate Biopharmaceuticals, Inc
Added as a member of the broad-market Russell 3000®, 2000® and Microcap® IndexesInnovate plans to host a Clinical and Scientific Update on September 6, 2018, in New York CityMultiple research...
Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City
03 août 2018 07h05 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...
Innovate Biopharmaceuticals Enters into a Collaboration on Larazotide’s Effect on Improving the Microbiome of Children with EED with the University of Virginia School of Medicine
31 juil. 2018 07h00 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., July 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc. (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and...
Innovate Biopharmaceuticals Enters into an R&D Collaboration on Larazotide’s Corrective Effect on the Dysfunctional Intestinal Barrier and the Dysfunctional Microbiome in various Diseases with the University of Maryland School of Medicine
28 juin 2018 07h00 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., June 28, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc. (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and...